SCHEMBL600267

SCHEMBL600267

CCC(C(=O)O)c1ccsc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 9/20 0.44
AKR1C2 P52895 9/20 0.44
AKR1C1 Q04828 1/20 0.44
PTGS1 P23219 1/20 0.44
ALOX5 P09917 1/20 0.44
PPARG P37231 1/20 0.40
PPARA Q07869 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA4 P43681 1/20 0.40
LCK P06239 1/20 0.39
FYN P06241 1/20 0.39
DAO P14920 1/20 0.39
SLC1A3 P43003 2/20 0.37
SLC1A2 P43004 2/20 0.37
SLC1A1 P43005 2/20 0.37
HTR1A P08908 1/20 0.37
ADRA1A P35348 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15412644 0.86 ALOX5 (0.41) ALOX5PPARGPPARACHRNB2CHRNB4
SCHEMBL14713063 0.83 ALOX5 (0.41) PTGS1ALOX5PPARGPPARACHRNB2
SCHEMBL27275524 0.82 ALOX5 (0.41) PTGS1ALOX5PPARGPPARACHRNB2
SCHEMBL113145 0.81 ALOX5 (0.44) ALOX5PPARGPPARACHRNB2CHRNB4
SCHEMBL10683115 0.81 CHRNB2 (0.43) ALOX5CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL27510765 0.81 ALOX5 (0.44) AKR1C3PTGS1ALOX5PPARGPPARA
SCHEMBL11362145 0.81 CHRNB2 (0.43) ALOX5CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL1095592 0.81 ALOX5 (0.44) PTGS1ALOX5PPARGPPARACHRNB2
Hydrochloric Acid SCHEMBL111897 0.80 ALOX5 (0.42) ALOX5PPARGPPARACHRNB2CHRNB4
SCHEMBL1494183 0.80 ALOX5 (0.40) ALOX5CHRNB2CHRNB4CHRNA3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11819833-B2 Conducting polymer and carbon nitride based nanocomposite photocatalyst for degradation of aqueous organic pollutants Najran University (SA) 2023-11-21 US disclosed
US-20230330644-A1 CONDUCTING POLYMER AND CARBON NITRIDE BASED NANOCOMPOSITE PHOTOCATALYST FOR DEGRADATION OF AQUEOUS ORGANIC POLLUTANTS Najran University (SA) 2023-10-19 US disclosed
US-11713397-B1 Composition for forming corrosion resistant composite coating KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2023-08-01 US disclosed
US-11530327-B1 Saltwater corrosion-resistant composite coating KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2022-12-20 US disclosed
US-11447645-B1 Saltwater corrosion resistant hybrid composite KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2022-09-20 US disclosed
EP-4041249-A1 COMPOSITIONS AND METHODS FOR IN VIVO SYNTHESIS OF UNNATURAL POLYPEPTIDES The Scripps Research Institute (US) 2022-08-17 EP disclosed
WO-2022170108-A1 PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF IN PREVENTION OF RADIATION INJURY AILERON THERAPEUTICS, INC. (US) 2022-08-11 WO disclosed
US-10626087-B2 Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use of the same LOYOLA UNIVERSITY OF CHICAGO (US) 2020-04-21 US disclosed
US-20180170898-A1 BETA- AND GAMMA-AMINO-ISOQUINOLINE AMIDE COMPOUNDS AND SUBSTITUTED BENZAMIDE COMPOUNDS ALCON INC. (CH) 2018-06-21 US disclosed
US-9884840-B2 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds AERIE PHARMACEUTICALS, INC. (US) 2018-02-06 US disclosed
US-5532025-A Corrosion inhibiting compositions ZIPPERLING KESSLER & CO. (GMBH & CO.) (DE) 1996-07-02 US disclosed
EP-0712336-A1 CORROSION INHIBITING MULTILAYER COATING MONSANTO COMPANY (US) 1996-05-22 EP disclosed
CN-1121074-A Novel N-pyridyl carboxamides and derivatives, processes for their preparation and the pharmaceutical compositions which contain them ADIR (FR) 1996-04-24 CN disclosed
WO-1995003136-A1 CORROSION INHIBITING MULTILAYER COATING MONSANTO COMPANY (US) 1995-02-02 WO disclosed
CN-1097752-A Benzocyclohepta alkene, benzoxepines and benzo thia MERCK PATENT GMBH (DE) 1995-01-25 CN disclosed
US-5314910-A 2-Heteroaromatic alkanoate esters useful as inhibitors of human leukocyte or neutrophil elastase CORTECH INC. (US) 1994-05-24 US disclosed
US-5240956-A Phenyl 2-heteroaromatic-alkanoates, elastase inhibitors CORTECH, INC. (US) 1993-08-31 US disclosed
EP-0484949-A2 Ester inhibitors CORTECH, INC. (US) 1992-05-13 EP disclosed
EP-0221806-B1 SUBSTITUTED THIOPHENE-2-SULFANOMIDE AND ANTIGLAUCOMA COMPOSITIONS CONTAINING THEM MERCK & CO. INC. (US) 1990-01-10 EP disclosed
EP-0221806-A1 Substituted thiophene-2-sulfanomide and antiglaucoma compositions containing them MERCK & CO. INC. (US) 1987-05-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10626087-B2 Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use of the same MGAM, INMT, NNMT AKR1C3 3613/4885AKR1C2 2575/4885AKR1C1 2398/4885
US-20180170898-A1 BETA- AND GAMMA-AMINO-ISOQUINOLINE AMIDE COMPOUNDS AND SUBSTITUTED BENZAMIDE COMPOUNDS PRKCQ, UACA, BCAT2 AKR1C3 2535/4885AKR1C2 1631/4885AKR1C1 1661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.